All Stories

  1. Successful Treatment of Nail Lichen Planus with a Lacquer Containing Urea, Keratinase, and a Retinoid Molecule: Report of 10 Cases
  2. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
  3. Assessment of clinical efficacy of lidocaine/tetracaine 7%/7% peel cream in fractional microablative laser procedure‐associated pain for facial skin aging treatment. A randomized, controlled, single‐blind trial
  4. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study
  5. Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss a...
  6. Efficacy and tolerability of a cream containing modified glutathione (GSH‐C4), beta‐Glycyrrhetic, and azelaic acids in mild‐to‐moderate rosacea: A pilot, assessor‐blinded, VISIA and ANTERA 3‐D analysis, two‐center study (The “Rosazel” Trial)
  7. Efficacy of lidocaine 7 %, tetracaine 7 % self-occlusive cream in reducing MAL-cPDT-associated pain in subjects with actinic keratosis: A randomized, single-blind, vehicle-controlled trial (The “3P-Trial”)
  8. Efficacy and Tolerability of Topical Polyphenon E in Multiple “Seborrheic Keratosis-Like” Lesions of the Groin in an Immunocompetent 26-Year-Old Man
  9. Treatment of brittle nail with a hydroxypropyl chitosan‐based lacquer, alone or in combination with oral biotin: A randomized, assessor‐blinded trial
  10. Generalized verrucosis: A therapeutic challenge: Efficacy of topical sinecatechins (Veregen) 10%
  11. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial
  12. Topical purified omental lipid formulations in the prevention of skin ulcers: a narrative review
  13. Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the fa...
  14. Skin protective effects of an antipollution, antioxidant serum containing Deschampsia antartica extract, ferulic acid and vitamin C: a controlled single-blind, prospective trial in women living in urbanized, high air pollution area
  15. Topical sinecatechins in the treatment of verrucae planae of the face
  16. Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial
  17. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial
  18. Efficacy and Safety of Intralesional Methotrexate in the Treatment of a Large Keratoacanthoma of the Dorsal Hand in a 99-Year-Old Woman
  19. Anti-Aging Efficacy of Melatonin-Based Cream: Clinical and Instrumental Skin Evaluation
  20. Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the “S.O. Sweet” study: a proof-of-concept pilot trial
  21. Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study
  22. Anti-Aging Efficacy of Melatonin-Based Cream: Clinical and Instrumental Skin Evaluation
  23. Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessmen...
  24. Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial
  25. The efficacy and tolerability of 5‐aminolevulinic acid 5% thermosetting gel photodynamic therapy ( PDT ) in the treatment of mild‐to‐moderate acne vulgaris. A two‐center, prospective assessor‐blinded, proof‐of‐concept study
  26. Efficacy and Tolerability of Topical Green Tea Extract (Polyphenon E) Application in a “Therapy-Resistant” Plantar Wart
  27. Antiaging efficacy of melatonin-based day and night creams: a randomized, split-face, assessor-blinded proof-of-concept trial
  28. Behandlung der multiplen aktinischen Keratose und Feldkanzerisierung mit topischem Piroxicam 0,8% und Sonnenschutz (LSF 50+) bei Organtransplantat-Empfängern: Eine Serie von 10 Fällen
  29. A two-center, assessor-blinded, prospective trial evaluating the efficacy of a novel hypertonic draining cream for cellulite reduction: A Clinical and instrumental (Antera 3D CS) assessment
  30. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial
  31. Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases
  32. The 24-hour skin hydration and barrier function effects of a hyaluronic 1%, glycerin 5%, and Centella asiatica stem cells extract moisturizing fluid: an intra-subject, randomized, assessor-blinded study
  33. Prevention and treatment of venous thrombosis with therapeutic elastic tutors in different care settings. Clinical and hemodynamic evaluation and assessment of compliance to different treatments
  34. Efficacy and Tolerability of Polyphenon E in “Difficult-to-Treat” Multiple Genital Warts in an HIV-Positive Male Subject
  35. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial
  36. Protective effects ofPolypodium leucotomosextract against UVB-induced damage in a model of reconstructed human epidermis
  37. Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma
  38. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study
  39. Corrigendum
  40. Use of sunscreens with DNA repair components are more efficacious that sunscreen only in improving keratosis actinica patients clinical outcome after photodynamic therapy
  41. Efficacy of chlorhexidine, dexpanthenol, allantoin and chitosan gel in comparison with bicarbonate oral rinse in controlling post-interventional inflammation, pain and cicatrization in subjects undergoing dental surgery
  42. Emollient creams for face and body improve eczema in children with atopic dermatitis and help to restablish the normal skin flora
  43. Biorevitalizing effect of a novel facial serum containing apple stem cell extract, pro‐collagen lipopeptide, creatine, and urea on skin aging signs
  44. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients
  45. Compliance with drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne
  46. An urea, arginine and carnosine cream shows greater efficacy in the treatment of severe xerosis of the feet in type 2 diabetic patients in comparison with standard emollient glycerol cream.
  47. Use of a urea, arginine and carnosine cream versus a standard emollient glycerol cream for treatment of severe xerosis of the feet in patients with type 2 diabetes: a randomized, 8 month, assessor-blinded, controlled trial
  48. Preventive Long-Term Effects of a Topical Film-Forming Medical Device with Ultra-High UV Protection Filters and DNA Repair Enzyme in Xeroderma Pigmentosum: A Retrospective Study of Eight Cases
  49. Local rhamnosoft, ceramides and L‐isoleucine in atopic eczema: a randomized, placebo controlled trial
  50. Allergen-specific immunotherapy for allergic rhinitis in the elderly: is it never too late?
  51. An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, contr...
  52. Approaching atopic dermatitis treatment differently: from skin barrier preservation to allergen-specific immunotherapy
  53. A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
  54. Vaginal Use of Ibuprofen Isobutanolammonium (Ginenorm): Efficacy, Tolerability, and Pharmacokinetic Data: A Review of Available Data
  55. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream
  56. Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
  57. Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial
  58. The safety of a novel sublingual rush induction phase for latex desensitization
  59. Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: A prospective study
  60. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children Multicenter Trial
  61. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy
  62. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts
  63. D-dimer before chemotherapy might predict venous thromboembolism
  64. The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study
  65. Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial
  66. Sublingual Desensitization in Patients with Wasp Venom Allergy: Preliminary Results
  67. Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy – A cohort study
  68. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase
  69. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study
  70. Thrombophilias in pregnancy and their role in preeclampsia
  71. Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
  72. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial
  73. Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario)
  74. C-Reactive Protein in Hypertensive Disorders in Pregnancy
  75. Clobetasol propionate 0·05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial
  76. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial
  77. Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial
  78. Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid
  79. Recent progress in the therapeutic management of pre-eclampsia
  80. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial
  81. Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections
  82. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial
  83. Efficacy of AT in pre-eclampsia: a case-control prospective trial
  84. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial
  85. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial
  86. Evaluation of the Local Effects of Vitamin E ( E-Mousse®) on Free Radicals in Diabetic Microangiopathy: A Randomized, Controlled Trial
  87. Improvement of Microcirculation and Healing of Venous Hypertension and Ulcers with Crystacide. Evaluation of Free Radicals, Laser Doppler Flux and PO2. A Prospective- Randomized-Controlled Study
  88. Efficacy and safety of stabilised hydrogen peroxide cream (Crystacide) in mild-to-moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel
  89. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients
  90. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitisof the scalp: an open-label,multicentre, prospective trial on180 patients
  91. Evaluation of the efficacy and tolerability of oral terbinafine (DaskilR) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial
  92. Effect on vaginal pH of a polycarbophil vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis: a randomized, controlled study
  93. Long-Term Safety and Efficacy of Picotamide, a Dual-Action Antithromboxane Agent, in Diabetic Patients with Carotid Atherosclerosis: A 6-Year Follow-Up Study
  94. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients
  95. Antiaggregatory Effects of Picotamide in Long-Term Treatment: A 2-Year, Double-Blind Placebo-Controlled Trial
  97. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor
  98. Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease
  99. Audiometric Patterns of Genetic Non-syndromal Sensorineural Hearing Loss
  100. Effects of picotamide, an antiplatelet agent, on cardiovascular events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study
  101. Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?
  102. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors
  103. Safety and Efficacy of Picotamide, a Dual Anti-Thromboxane Agent, in Patients with Thrombocytosis and a Previous Thromboembolic Event: A 1-Year Observational Study
  104. Corrections
  105. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia
  106. Comparison of the effects of picotamide and aspirin on renal albumin excretion and cutaneous microcirculation in patients with type II diabetes mellitus: a pilot study
  107. Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia
  108. Effects of Picotamide, an Antithromboxane Agent, on Carotid Atherosclerotic Evolution
  109. Efficacy and safety of fluvastatin in elderly hypercholesterolemic patients: A pilot study
  110. Efficacy and Safety of Fluvastatin, a New HMG CoA Reductase Inhibitor, in Elderly Hypercholesterolaemic Women
  111. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.
  112. Isradipine in the Treatment of Peripheral Occlusive Vascular Disease of the Lower Limbs: A Pilot Study
  113. A Progress Report on the Localization of Usher Syndrome Type II to Chromosome 1q
  114. Genetic Studies of Usher Syndrome
  115. t-PA, PAI, and Protein C Before and After Vascular Occlusion of the Upper Limb in Patients with Raynaud's Phenomenon
  116. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon
  117. Localization of Usher syndrome type II to chromosome 1q
  118. Effects of Ticlopidine and Indobufen on Platelet Aggregation Induced by A23187 and Adrenaline in the Presence of Different Anticoagulants